Artificial intelligence is dominating headlines, telehealth has settled into a new normal, and digital health continues to promise transformation. However, much of what is being discussed in healthcare today reflects potential rather than reality.
The gap between what is possible and what is actually happening in clinical practice remains wide. This article focuses on separating signal from noise and highlights the trends clinicians should pay attention to now.
Key Takeaways
- AI is advancing quickly, but real clinical adoption and validation remain limited.
- Mental health demand continues to outpace how primary care is structured to deliver it
- Patient digital readiness is still being overlooked, despite its impact on outcomes.
- Remote patient monitoring is entering a phase of scrutiny after years of expansion
- Cost pressures remain one of the most consistent drivers of patient behavior.
AI in Healthcare: What Is Actually Changing Clinical Practice?
Why AI Adoption in Healthcare Still Lags Behind the Hype
Research from Anthropic suggests that AI could perform a large share of tasks across multiple industries. In practice, however, adoption remains far below that level.
This gap is often framed as an untapped opportunity. It is more accurately understood as a reflection of how difficult it is to integrate AI into real clinical workflows. Healthcare is not a controlled environment, and tools that perform well in theory often struggle in practice.
Vendor-driven narratives tend to emphasize future potential. The more relevant question for clinicians is whether these tools improve care today.
Most Healthcare AI Tools Lack Real-World Clinical Validation
A meta-analysis in Nature Medicine found that fewer than 1% of studies on large language models were conducted in live clinical settings. Most evidence still comes from simulated or synthetic settings.
This is a critical limitation. Healthcare does not operate in controlled conditions, and results from simulated environments often overstate real-world performance.
There is a growing volume of research on AI, but relatively little of it answers the question that matters most: Does it improve patient care in practice?
How AI Improves Efficiency but Can Weaken Clinical Judgment
Research in Computers in Human Behavior shows that AI can improve performance when used alongside humans. At the same time, it increases overconfidence.
AI tools tend to reinforce existing assumptions rather than challenge them. This creates a risk that clinicians may feel more confident without being more accurate.
Implication for clinicians: AI is most useful when it is treated as something to challenge, not something to trust by default. The risk is not that AI replaces clinicians, but that it subtly alters decision-making in ways that are harder to detect.
Mental Health Demand Is Reshaping Primary Care Delivery
Data from Medscape shows that more than half of primary care clinicians frequently encounter patients with mental health needs.
This is no longer a secondary issue. Mental health has effectively become a core component of primary care, yet most systems are not structured to support it.
Clinicians face predictable constraints:
- Limited time.
- Limited training.
- Unclear reimbursement pathways.
These are not new problems, but they are becoming more consequential as demand increases.
Implication for clinicians: The current model of referring out or addressing mental health within a limited visit time is increasingly insufficient. Structural changes, not incremental adjustments, will likely be required.
Patients Are Using AI for Health Information and Symptom Support
Data from Microsoft and the Kaiser Family Foundation shows that patients are already integrating AI into their health management.
This is not a future trend. It is already happening, often outside the visibility of clinicians.
Patients use these tools for symptom checking, education, and emotional support, particularly during hours when access to care is limited. Accuracy is not always the primary concern. Immediacy is.
Implication for clinicians: The question is no longer whether patients will use these tools. The question is whether clinicians acknowledge and incorporate that reality into care delivery.
Why Patient Digital Readiness Matters in Digital Health Adoption
Despite ongoing investment in digital health, many organizations still do not assess whether patients can effectively use these tools. Research from UCSF highlights that digital readiness is often assumed rather than measured.
This assumption creates a disconnect. Healthcare systems continue to deploy digital solutions, while some patients cannot meaningfully engage with them.
Implication for clinicians: Digital access is not the same as digital readiness. Without addressing this gap, additional technology may widen disparities rather than reduce them.
Telehealth Utilization Trends: From Pandemic Surge to Long-Term Normalization
Data from FAIR Health shows that telehealth has reached a steady baseline after its pandemic-driven surge.
This stabilization is often interpreted as a plateau. It is more accurately viewed as a normalization phase, where telehealth is finding its appropriate role within care delivery.
Mental health remains the dominant use case, reinforcing where virtual care provides the most value.
Telehealth Adoption Remains Lower in Rural Communities
Research in JAMA Network Open shows that telehealth adoption is significantly lower in rural areas, despite being positioned as a solution for access challenges.
This suggests that access issues are more complex than availability alone. Infrastructure, literacy, and trust all play a role.
Implication for clinicians: Expanding telehealth access requires more than offering virtual visits. It requires addressing the underlying barriers that prevent adoption.
Remote Patient Monitoring Faces Growing Pressure to Prove Value
Remote patient monitoring expanded rapidly, supported by favorable reimbursement and strong expectations. That phase is ending.
Analysis from Trilliant Health indicates that payers are increasingly questioning its value.
This shift was predictable. Technologies that scale quickly without consistent outcome data eventually face scrutiny.
Implication for clinicians: The focus is shifting from adoption to justification. Programs that demonstrate clear clinical value will persist, while others may not.
Healthcare Costs Continue to Influence Patient Care Decisions
Data from the Kaiser Family Foundation Health System Tracker shows that cost remains a consistent barrier to care.
Patients are delaying or avoiding care, and many are concerned about their ability to pay. Price transparency efforts have improved visibility but have not meaningfully changed behavior or outcomes.
This reflects a broader issue. Information alone does not change decisions when underlying costs remain high.
Implication for clinicians: Cost is not a secondary concern for patients. It is often a primary factor influencing whether care is pursued at all.
Healthcare Technology Is Entering an Era of Accountability
Healthcare is moving out of a phase defined by rapid innovation and into one defined by accountability. The focus is shifting from what technology can do to what it actually delivers.
AI, telehealth, and digital tools will continue to evolve. The differentiator will not be access to technology, but the ability to implement it in ways that improve real outcomes.
Clinicians and healthcare organizations that focus on practical integration, patient readiness, and measurable value will be better positioned to navigate this shift.
Disclosures:
- The author serves as Head of Strategy at Doxy.me, the telehealth technology company that owns telehealth.org.
- The views expressed in this commentary are those of the author and do not necessarily reflect the views of Telehealth.org.
- AI tools may have assisted in drafting or editing; the author or editorial team reviewed and approved all content.
- This article is not legal or medical advice.
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Scientists Create Tiny “Mini Livers” That Could One Day Replace Liver Transplants
Engineered tissue grafts could help perform key liver functions and benefit thousands of people living with liver failure. The liver is one of the body’s hardest-working organs, carrying out hundreds of vital jobs, from [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
Scientists Discover Surprising Way To Help the Brain Recover After Stroke
A new study suggests that strengthening the body’s natural circadian rhythms may help the brain recover after stroke, even when treatment begins days after the injury. Every year, millions of people survive a stroke, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Younger Generations Are Aging Faster – and It May Be Fueling a Surge in Cancer
Younger generations may be aging biologically faster than those before them, and that shift could help explain rising rates of cancer at younger ages. For decades, cancer was viewed largely as a disease of [...]
Using Cannabis Could Raise Your Stroke Risk by 37%, Massive Study Reveals
Large-scale evidence suggests cannabis, cocaine, and amphetamines may directly raise stroke risk, including in younger adults. As recreational drug use becomes increasingly common, researchers are uncovering evidence that its health consequences may extend far beyond [...]
Could Vitamin C Be the Secret to Keeping Your Brain Younger?
Lower vitamin C levels were linked to reduced brain volume and weaker neural connectivity in older adults, suggesting a potential connection between nutrition and brain health. Could a common vitamin help preserve the brain [...]
This Deadly Disease Was Wiping Out Humans 5,500 Years Ago
A new study suggests plague was already a deadly threat 5,500 years ago, striking small hunter-gatherer communities long before cities and agriculture emerged. For centuries, plague has been remembered as the disease that devastated [...]
China closing in but US leads in biotech quality, commercial reach, survey finds
SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials, opens new tab than the U.S., still lags in the quality and commercial reach of its biomedical science, according to a recent survey, opens new [...]
New method generates renewable supply of progenitor immune cells
In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help [...]
Scientists Just Discovered a Cellular Survival System That Was Never Supposed To Exist
A surprising backup pathway allows cells to make a crucial amino acid when their primary machinery fails. For decades, biologists believed cells had only one way to access a molecule they cannot live without. New [...]
Artificial cells gain porous membranes, enabling lab reactions and drug release
Artificial cells created in the laboratory offer a wide range of potential applications. Until now, however, their membranes—unlike those of real cells—have been virtually impermeable. Researchers at the Max Planck Institute for Polymer Research, [...]
Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk
Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, [...]
Stanford Scientists Discover Explosive New Type of Immune Cell
Scientists studying the remarkable regenerative abilities of planarian flatworms have uncovered a previously unknown type of immune cell with an unusually destructive defense strategy. What if an immune cell could wipe out nearby threats [...]
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma. Vida Ventures led the raise, with the venture [...]
Joint initiative of 5 EU countries calls for ‘unified approach’ to pharma framework amid US drug pricing pressure
With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries is calling for a “unified approach” to strengthen Europe’s pharmaceutical framework and access to innovative medicines. Belgium, the Netherlands, [...]















